Hospira Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

HOSPIRA has five hundred and eighteen approved drugs.

There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.

There are sixty-nine patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and eight supplementary protection certificates in sixteen countries.

International Patents:	69
US Patents:	9
Tradenames:	333
Ingredients:	210
NDAs:	518
Patent Litigation for Hospira:	See patent lawsuits for Hospira
PTAB Cases with Hospira as petitioner:	See PTAB cases with Hospira as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070691-001	Jun 19, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira Inc	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065293-002	Aug 10, 2006		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira Inc	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	200795-002	Aug 4, 2011	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Hospira	AMINOCAPROIC ACID	aminocaproic acid	INJECTABLE;INJECTION	070888-001	Jun 16, 1988		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	INJECTABLE;INJECTION	075240-001	Nov 29, 1999	AP	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Hospira	STERILE WATER FOR INJECTION	sterile water for injection	LIQUID;N/A	018801-002	Oct 27, 1982	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Hospira	MAGNESIUM SULFATE IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	020309-001	Jun 24, 1994	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira	TRACRIUM PRESERVATIVE FREE	atracurium besylate	INJECTABLE;INJECTION	018831-001	Nov 23, 1983	4,179,507	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-003	Mar 13, 2013	4,910,214*PED	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-002	Mar 13, 2013	4,910,214*PED	⤷ Try a Trial
Hospira	BRETYLOL	bretylium tosylate	INJECTABLE;INJECTION	017954-001	Approved Prior to Jan 1, 1982	RE29618	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-001	Dec 17, 1999	6,716,867*PED	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-002	Mar 13, 2013	6,716,867*PED	⤷ Try a Trial
Hospira Inc	NIPENT	pentostatin	INJECTABLE;INJECTION	020122-001	Oct 11, 1991	3,923,785	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	4 mcg/mL, 50 mL and 100 mL vials	➤ Subscribe	2013-12-26
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	100 mcg/mL	➤ Subscribe	2009-04-08
➤ Subscribe	Injection	4 mcg/mL, 20 mL vials	➤ Subscribe	2015-09-30

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0275821	SPC/GB01/039	United Kingdom	⤷ Try a Trial	PRODUCT NAME: ZOLEDRONIC ACID OPTIONALLY IN THE FORM OF A SALT THEREOF; NATIONAL REGISTRATION NO/DATE: EU/1/01/176/001-003 20010320; FIRST REGISTRATION: CH 55463 20001128
2957286	6/2019	Austria	⤷ Try a Trial	PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721
1853250	132014902271575	Italy	⤷ Try a Trial	PRODUCT NAME: PACLITAXEL LEGATO ALL'ALBUMINA FORMULATO IN NANOPARTICELLE(ABRAXANE); AUTHORISATION NUMBER(S) AND DATE(S): EU/01/07/428, 20131220
1635783	122014000024	Germany	⤷ Try a Trial	PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
1115417	06C0022	France	⤷ Try a Trial	PRODUCT NAME: DAPTOMYCINE; REGISTRATION NO/DATE: EU/1/05/328/001-002 20060119
0219829	SPC/GB06/034	United Kingdom	⤷ Try a Trial	PRODUCT NAME: CLOFARABINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/06/334/001 20060529; UK EU/1/06/334/002 20060529; UK EU/1/06/334/003 20060529; UK EU/1/06/334/004 20060529
2957286	2018C/047	Belgium	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.